R. Gregory

发表

Prognostic relavance of cerbB2 expression following neoadjuvant chemotherapy in patients in a randomised trial of neoadjuvant versus adjuvant chemoendocrine therapy

T. Powles, M. Dowsett, Jenny C. Chang, 2004, Breast Cancer Research and Treatment.

Prediction of clinical outcome from primary tamoxifen by expression of biologic markers in breast cancer patients.

T. Powles, M. Dowsett, Jenny C. Chang, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Vinorelbine – a clinical review

I. Smith, R. Gregory, 2000, British Journal of Cancer.

Mitomycin C, vinblastine and cisplatin (MVP): an active and well-tolerated salvage regimen for advanced breast cancer

L. Assersohn, S. Johnston, A. Urruticoechea, 2005, British Journal of Cancer.

Clinical studies of apoptosis and proliferation in breast cancer.

T. Powles, M. Dowsett, L. Assersohn, 1999, Endocrine-related cancer.

Variation in endometrial thickening in women with amenorrhea on tamoxifen

T. Powles, M. Dowsett, S. Ashley, 1998, Breast Cancer Research and Treatment.

Combining platinum, paclitaxel and anthracycline in patients with advanced gynaecological malignancy.

M. Gore, R. A’Hern, D. Barton, 2000, European journal of cancer.

Investigating lymphadenopathy—report on the first 12 months of the lymph node diagnostic clinic at the Royal Marsden Hospital

A. Wotherspoon, D. Cunningham, G. Middleton, 2000, Postgraduate medical journal.

Mitomycin C, vinblastine and carboplatin: effective outpatient chemotherapy for advanced non-small cell carcinoma of the lung (NSCLC).

I. Smith, M. O'Brien, R. Gregory, 2001, Clinics in oncology.

The effect of tamoxifen and hormone replacement therapy on serum cholesterol, bone mineral density and coagulation factors in healthy postmenopausal women participating in a randomised, controlled tamoxifen prevention study.

T. Powles, S. Ashley, J. Chang, 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

UFT/leucovorin plus bolus epirubicin and cyclophosphamide in advanced/metastatic breast cancer.

D. Miles, S. Johnston, I. Smith, 2000, Oncology.

Systemic candidiasis with candida vasculitis due to Candida kruzei in a patient with acute myeloid leukaemia

Ml Smith, A. Wotherspoon, R. Gregory, 1999, Bone Marrow Transplantation.

Biologic markers as predictors of clinical outcome from systemic therapy for primary operable breast cancer.

C. Osborne, T. Powles, M. Dowsett, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Studies of the Potential Utility of Ki67 as a Predictive Molecular Marker of Clinical Response in Primary Breast Cancer

T. Powles, M. Dowsett, L. Assersohn, 2003, Breast Cancer Research and Treatment.

Prediction of response to neoadjuvant chemoendocrine therapy in primary breast carcinomas.

T. Powles, M. Dowsett, A. Makris, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

Leukaemic infiltration or primary carcinoma of the breast in a patient with acute myeloid leukaemia

T. Powles, Jenny C. Chang, R. Gregory, 1997 .

Clubbing, arthralgia and haemoptysis in a patient with metastatic carcinoma of the breast.

T. Powles, J. Chang, R. Gregory, 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

A randomised trial of six versus twelve courses of chemotherapy in metastatic carcinoma of the breast.

T. Powles, J. Chang, R. Gregory, 1997, European journal of cancer.

Clinical and immunological assessment of Mycobacterium vaccae (SRL172) with chemotherapy in patients with malignant mesothelioma

A. Padhani, I. Smith, M. O'Brien, 2002, British Journal of Cancer.

Biological studies in primary medical therapy of breast cancer: The Royal Marsden Hospital experience

T. Powles, M. Dowsett, L. Assersohn, 1999 .